Medical-journals In Histology
Histological studies have been used to investigate the biological processes at work in the skin in chronic venous disease. A quantitative histological study has been reported in which three groups of patients was studied. The first was a group of patients with no evidence of skin changes as a consequence of their venous disease. The next group exhibited lipodermatosclerosis without a
history of ulceration. The third group had healed ulcers with residual lipodermatosclerosis. Patients with normal skin had a low number of white blood
cells visible (4 per mm2) in the upper 0.5 mm of the skin. There were eight times as many in patients with lip sclerotic skin, and 40 times as many in patients with healed venous ulcers. Subsequently an immunohistological study was undertaken to determine the types of white cell present in this infiltrate. The majority of
cells are macrophages with a T-lymphocyte component, but no excess of neutrophils compared with control sections taken from normal limbs. So this infiltrate is a reflection of a chronic inflammatory process. Histology remains the strongest predictor of outcome. In particular, anaplasia, defined by
cells showing irregular mitosis, enlarged nuclei, and hyperchromasia, portends a poorer outcome compared with favorable-histology (standard triphasic) tumors. Anaplasia is subdivided further into diffuse or focal categories.
High Impact List of Articles
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Skeletal muscle as an emerging therapeutic target in spinal and bulbar muscular atrophy
Soraru Gianni
Editorial: Clinical Investigation
-
Skeletal muscle as an emerging therapeutic target in spinal and bulbar muscular atrophy
Soraru Gianni
Editorial: Clinical Investigation
-
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process
Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
-
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process
Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
-
Emerging therapies for pulmonary arterial hypertension: a review of recently completed and ongoing clinical trials
Amresh Raina, Raymond L Benza
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for pulmonary arterial hypertension: a review of recently completed and ongoing clinical trials
Amresh Raina, Raymond L Benza
Review: Clinical Trail Outcomes: Clinical Investigation
-
Gender differences and clinical trial design
Sabine Oertelt-Prigione
Editorial: Clinical Investigation
-
Gender differences and clinical trial design
Sabine Oertelt-Prigione
Editorial: Clinical Investigation
Relevant Topics in Clinical